- Community driven business intelligence's Logo
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Owler - Community driven business intelligence's Logo
Hapten Sciences
3 Followers on Owler

Hapten Sciences

is a biopharmaceutical company that researches and develops drugs for the treatment of dermatological diseases...
Read more
OverviewCompetitorsFundingNews & Insights

Hapten Sciences

is a biopharmaceutical company that researches and develops drugs for the treatment of dermatological diseases...
Read more
Hapten Sciences President & CEO: Raymond J Hage

President & CEO

Raymond J Hage

CEO Approval Rating

85/100

2010

MemphisTennessee
Memphis Metropolitan Area

Private

Pharmaceuticals & Biotechnology
Life SciencesBiotechnology
2836 NAICS listing

https://www.haptensciences.com/

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$5.8M

News

Jun 19, 2019
The Business Journals: Memphis
Hapten Sciences: Memphis company, Ole Miss patent poison ivy 'vaccine'
Nov 19, 2015
BIOSPACE
Hapten Sciences: <b>Hapten Sciences</b> to Begin Clinical Trials for Novel Poison Ivy Vaccine
Nov 19, 2015
PR NEWSWIRE
Press Release: Hapten Sciences : Hapten Sciences to Begin Clinical Trials for Novel Poison Ivy Vaccine
Dec 19, 2014
CENTER WATCH
Hapten Sciences: RXi Pharmaceuticals, Hapten Pharmaceuticals ink agreement

Hapten Sciences Competitors

1Dermira
2Arcutis
3Dermata
4SCYNEXIS
5Amplyx
6Cidara Therapeutics
7Biscayne Pharmaceuticals
8Viamet Pharma
9Entasis
10Promentis
Unlock 14 + competitors

Trending Companies

    ABOUT

  • About Owler
  • Blog

    OFFERINGS

  • Owler Pro
  • Owler API
  • Owler Community

    SUPPORT

  • Support Center
  • Contact Support
  • Talk to Sales

    LEGAL

  • Accessibility
  • Terms & Conditions
  • Privacy

TOP INDUSTRIES

  • Software & Internet
  • Technology
  • Professional Services
  • Retail
  • Computer Companies
  • Health Care Companies
  • Fintech Companies
  • Banking Companies
Owler is now part of Meltwater

© 2026 Owler, Inc.